Diasorin SpA DSRLF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $102.06
- Day Range
- $107.40–107.40
- 52-Week Range
- $86.00–120.00
- Bid/Ask
- $95.62 / $108.10
- Market Cap
- $5.73 Bil
- Volume/Avg
- 1 / 27
Key Statistics
- Price/Earnings (Normalized)
- 19.54
- Price/Sales
- 4.82
- Dividend Yield (Trailing)
- 1.10%
- Dividend Yield (Forward)
- 1.17%
- Total Yield
- 1.48%
Company Profile
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 3,233
- Website
- https://www.diasoringroup.com
Comparables
Valuation
|
Metric
|
DSRLF
|
CIR
|
ISP
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.54 | 42.26 | 8.28 |
Price/Book Value | 3.44 | 0.81 | 1.14 |
Price/Sales | 4.82 | 0.26 | 2.48 |
Price/Cash Flow | 17.68 | 2.45 | 5.99 |
Price/Earnings
DSRLF
CIR
ISP
Financial Strength
|
Metric
|
DSRLF
|
CIR
|
ISP
|
|---|---|---|---|
Quick Ratio | 1.61 | 1.05 | — |
Current Ratio | 2.76 | 1.32 | — |
Interest Coverage | 7.33 | 1.78 | — |
Quick Ratio
DSRLF
CIR
ISP
Profitability
|
Metric
|
DSRLF
|
CIR
|
ISP
|
|---|---|---|---|
Return on Assets (Normalized) | 7.57% | 1.22% | 0.82% |
Return on Equity (Normalized) | 14.94% | 5.52% | 14.26% |
Return on Invested Capital (Normalized) | 11.85% | 2.72% | — |
Return on Assets
DSRLF
CIR
ISP
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Wflwkgfldy | Ztyv | $209.3 Bil | |
DHR
| Danaher Corp | Qnltqzqt | Ylxkfjf | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Ykfshngp | Jyzsq | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Jgnqhjdjh | Fgpvjtg | $41.5 Bil | |
A
| Agilent Technologies Inc | Wzbvmdyd | Kgxg | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Pcmwjpfv | Qmsbm | $26.5 Bil | |
ICLR
| Icon PLC | Nzyqryyk | Lpzcc | $24.8 Bil | |
ILMN
| Illumina Inc | Hnklksqph | Nvvzn | $19.5 Bil | |
WAT
| Waters Corp | Gcrscdzns | Trk | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Tngshvsrh | Zhzzdwv | $17.5 Bil |